beta-D-Glcp-(1->3)-[beta-D-Glcp-(1->4)]-alpha-D-Galp

Term ID

CHEBI:147174

Synonyms

(2S,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6S)-5,6-dihydroxy-2-(hydroxymethyl)-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
beta-D-gluco-hexopyranosyl-(1->3)-[beta-D-gluco-hexopyranosyl-(1->4)]-alpha-D-galacto-hexopyranose
beta-D-glucopyranosyl-(1->3)-[beta-D-glucopyranosyl-(1->4)]-alpha-D-galactopyranose
Glc(b1-3)[Glc(b1-4)]a-Gal

Definition

A trisaccharide that is α-D-galactopyranose in which the hydroxy groups at positions 3 and 4 have been converted into the corresponding β-D-glucopyranosides.

References

glygen:G10507RU
glytoucan:G10507RU

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Glcp-(1->3)-[beta-D-Glcp-(1->4)]-alpha-D-Galp

Phenotype where environments contain beta-D-Glcp-(1->3)-[beta-D-Glcp-(1->4)]-alpha-D-Galp

Phenotype modified by environments containing beta-D-Glcp-(1->3)-[beta-D-Glcp-(1->4)]-alpha-D-Galp

Phenotype affecting beta-D-Glcp-(1->3)-[beta-D-Glcp-(1->4)]-alpha-D-Galp

Human Disease Model